Federico Asch, MD, FACC, FASE, has assumed the directorship of the Cardiovascular Core Laboratories at MedStar Health, which has provided services for more than 150 multi-center trials, including multiple studies on the effects of medications on valvular and ventricular function, prosthetic valve assessments and intracoronary therapies. Dr. Asch succeeds Neil Weissman, MD, who is president of the MedStar Health Research Institute.
Dr. Asch’s own research is focused on myocardial viability, 3-D echocardiography, contrast echocardiography, and structural heart disease. He has been widely published in a number of nationally respected professional journals, and serves as principal investigator for the Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) study sponsored by NHLBI. He also is co-investigator for the Surgical Treatment for Ischemic Heart Failure (STICH) trial sponsored by NIH, and the WASE normal valves study sponsored by the American Society of Echocardiography and MedStar.
Dr. Asch says of his new position, “In this very successful and highly respected lab developed by Dr. Weissman, I hope to further expand our operations to areas of new need in the growing world of cardiac imaging and structural heart disease, specifically to expand our presence in the percutaneous treatment of mitral and tricuspid valve disease and our cardiac CT/MRI core lab services. In addition, I hope to expand our scientific productivity with MedStar investigator-initiated projects.”
Dr. Asch is a graduate of the Universidad de Buenos Aires Medical School and completed a cardiology fellowship at Instituto Cardiovascular de Buenos Aires in Argentina. He completed an echocardiography fellowship, and his residency and fellowship in cardiovascular disease at the MedStar Georgetown University Hospital/MedStar Washington Hospital Center/DC VA Medical Center program.
Jonathan Patrick, MD, Cardiology, received the 2017 Nurses’ Choice Physician Collaboration Award at MedStar Washington Hospital Center during Nurses Week in May. Awards are given to clinicians whom nurses feel represent the best in teamwork and excellence in patient care.
“For our physician colleagues,” says Susan Eckert, RN, MSN, senior vice president and chief nursing executive, during the awards ceremony,“this means that you have gone the extra mile to sustain a high reliability team that encourages and supports those who put patients first.” Comments by the nurses included, “The best doctor ever. Always gentle, and if something is needed he provides it immediately. Always engaging the new nurses and taking them into consideration. An amazing cardiologist. Every doctor should be like him.”
New Medical Staff
Reza Abrishamchian, MD, has joined the staff of MedStar Heart & Vascular Institute (MHVI) as a cardiac surgeon at MedStar Union Memorial Hospital in Baltimore, Md. Prior to joining MHVI, Dr. Abrishamchian served as chief of cardiac surgery at the Washington Health System in Washington, Pa. He is board certified by the American Board of Surgery and the American Board of Thoracic Surgery. A graduate of the St. George’s University School of Medicine, Grenada, West Indies, Dr. Abrishamchian received a master in public health in epidemiology from Emory University’s Rollins School of Public Health, in Atlanta, Ga. He completed his post-graduate training at the University of Maryland Medical Center where he served as chief resident of cardiothoracic surgery. He also served as chief resident in general surgery at the Albany Medical Center, Albany, NY. Dr. Abrishamchian also completed fellowships in minimally invasive cardiac surgery research and a post-doctoral research fellowship in cardiothoracic surgery research focusing on heart failure and cardiac assist devices at The Ohio State University. Dr. Abrishamchian’s clinical interests include: Coronary artery bypass grafting (CABG) | Heart valve surgery, repair and replacement including TAVR | Aortic reconstruction including endografts | Ventricular assist devices and heart failure surgery
Malik AlOmari, MD, is joining MedStar Heart & Vascular Institute (MHVI) as a cardiologist at MedStar Southern Maryland Hospital Center in Clinton, Md. Dr. Al-Omari comes to MHVI from the Mayo Clinic Health System where he was an assistant professor of medicine and an interventional cardiologist. Dr. Al-Omari is board certified in interventional cardiology, cardiovascular disease, echocardiography, nuclear cardiology and internal medicine. His research has been published in numerous prestigious journals, and has primarily focused on an improved understanding of hypertension in African-Americans. He received his medical degree from Jordan University of Science and Technology and completed his interventional cardiology fellowship at the University of Tennessee Health Center, Memphis. He completed a fellowship in cardiology at the Mayo Clinic (Jacksonville) Program and an advanced heart failure and transplantation fellowship at the Mayo Clinic in Rochester. Dr. Al-Omari served his residency in internal medicine residency at Seton Hall University School of Health and Medical Sciences Program, South Orange, NJ. Dr. Al-Omari’s clinical and research interests include: General cardiology | Interventional cardiology | Peripheral vascular disease (PVD) | Heart failure | Echocardiography | Heart disease in minority populations